Results 11 to 20 of about 4,592 (135)

Differential expression of estrogen receptor subtypes in ovarian high‐grade serous carcinoma and clear cell carcinoma

open access: yesReproductive Medicine and Biology, 2021
Purpose To investigate the role of estrogen receptors (ERs) in high‐grade serous carcinoma (HGSC) and clear cell carcinoma (CCC) of the ovary and evaluate ERs as prognostic biomarkers for ovarian cancer. Methods This study included 79 patients with HGSC (
Daiken Osaku   +8 more
doaj   +1 more source

GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma

open access: yesFrontiers in Oncology, 2021
Hepatocellular carcinoma (HCC) is an aggressive malignancy with a poor prognosis. Effective biomarkers and specific therapeutic targets for HCC are therefore urgently needed.
Yu-an Qiu   +14 more
doaj   +1 more source

Neonicotinoid insecticides promote breast cancer progression via G protein-coupled estrogen receptor: In vivo, in vitro and in silico studies

open access: yesEnvironment International, 2022
Neonicotinoid insecticides (NIs) have been widely detected in environmental media and human body with concentrations reaching hundreds of nanomolar to micromolar levels.
Xin Li   +9 more
doaj   +1 more source

The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer. [PDF]

open access: yesPLoS ONE, 2014
INTRODUCTION:The G protein-coupled estrogen receptor (GPER) is a novel estrogen receptor that mediates proliferative effects induced by estrogen but also by tamoxifen.
Eleftherios P Samartzis   +5 more
doaj   +1 more source

Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway.

open access: yesPLoS ONE, 2022
G protein-coupled estrogen receptor (GPER) was reported to be a potential target in the breast cancer therapy. This study aimed to illuminate the function of GPER and its mediated PI3K/AKT pathway in cryptotanshinone (CPT) inducing cell apoptosis and ...
Danning Shi   +6 more
doaj   +2 more sources

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

open access: yesJournal of Ovarian Research, 2012
Background Even though ovarian tumors are not generally considered estrogen-sensitive, estrogens may still have an impact on ovarian tumor progression. The recently identified trans-membrane estrogen receptor GPER is involved in rapid estrogen signaling.
Kolkova Zuzana   +6 more
doaj   +1 more source

Molecular identification of bulbospinal ON neurons by GPER, which drives pain and morphine tolerance

open access: yesThe Journal of Clinical Investigation, 2023
The rostral ventromedial medulla (RVM) exerts bidirectional descending modulation of pain attributable to the activity of electrophysiologically identified pronociceptive ON and antinociceptive OFF neurons.
Yingfu Jiao   +23 more
doaj   +1 more source

Synthesis and characterization of tricarbonyl-Re/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30. [PDF]

open access: yesPLoS ONE, 2012
The discovery of the G protein-coupled estrogen receptor GPER (also GPR30) and the resulting development of selective chemical probes have revealed new aspects of estrogen receptor biology.
Ritwik Burai   +6 more
doaj   +1 more source

The Role of G Protein-Coupled Estrogen Receptor (GPER) in Vascular Pathology and Physiology

open access: yesBiomolecules, 2023
Objective: Estrogen is indispensable in health and disease and mainly functions through its receptors. The protection of the cardiovascular system by estrogen and its receptors has been recognized for decades.
Fujie Xu   +7 more
doaj   +1 more source

The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells

open access: yesCells, 2019
The inhibition of the G protein-coupled estrogen receptor (GPER) offers promising perspectives for the treatment of breast tumors. A peptide corresponding to part of the hinge region/AF2 domain of the human estrogen receptor α (ERα17p, residues 295–311 ...
Rosamaria Lappano   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy